HB907

Provides civil and criminal immunity for the distribution or use of Naloxone and other opioid antagonists beyond their shelf-life end date

Complete·5/15/26

Louisiana HB907 grants immunity from civil and criminal liability for the distribution or use of Naloxone and other opioid antagonists beyond their.

Louisiana HB907 provides immunity from civil and criminal liability for individuals who distribute or use Naloxone or other opioid antagonists after their shelf-life end date, provided they act in good faith. This immunity does not apply in cases of gross negligence or willful misconduct. The law also shields healthcare professionals from disciplinary actions by professional licensing boards when they are granted immunity under this act.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

Roll Call Votes

35 Yea

RRRRRRRRRDRDDRRRRDDRRRRRDRRRDDRRRRD

0 Nay

4 Absent

RDRD

Calendar

Apr 22

9:00 AM

Senate Committee on Health and Welfare

Mar 25

9:00 AM

House Committee on Health and Welfare

History

May 15

House

Signed by the Governor. Becomes Act No. 183.

May 15

House

Effective date: 05/15/2026.

May 13

House

Sent to the Governor for executive approval.